Effective August 2, 2022, mdxhealth has acquired the Oncotype DX Genomic Prostate Score (GPS) test from Exact Sciences. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the press release.
Questions? Email: gps@mdxhealth.com

Explore the Report

How to Interpret the Oncomap™ Report

The Oncomap test report provides clear, clinically actionable test results that are easy to interpret, helping the physician and patient to make confident, informed treatment decisions. The report offers therapeutic options and available clinical trials based on the patient’s key biomarkers, as well as detailed information on the patient’s specimen and genomic findings.

Getting the results

Most Oncomap results are available within 7 days from the date the specimen is received in the Exact Sciences lab. You can access the results through the online physician portal or receive the report by fax.